Month: October 2023
-
E-Filing and E-Service Advancements
In today’s fast-paced digital world, the legal landscape has not remained untouched by technological advancements. One of the most significant developments in the legal sector is the adoption of E-Filing and E-Service systems. These innovations have revolutionized how legal documents are filed, served, and managed, making the legal process more efficient, cost-effective, and environmentally friendly.…
-
Impact of Data Privacy Laws on Legal Tech
The legal technology, or “legal tech,” industry has undergone a remarkable transformation in recent years, largely driven by the increasing importance of data privacy laws. In an era where information is more valuable than ever before, protecting sensitive data has become paramount. As a result, legal tech companies are finding themselves at the forefront of…
-
Legal Tech Startups and Innovation Hubs
In the ever-evolving landscape of the legal industry, the emergence of legal tech startups and innovation hubs has ushered in a new era of transformation and innovation. These dynamic entities are reshaping the way legal services are delivered, making them more accessible, efficient, and technologically advanced. In this comprehensive article, we will explore the world…
-
Role of Natural Language Processing in Legal Tech
In the ever-evolving landscape of technology, the legal sector has not remained untouched. The integration of cutting-edge innovations like Artificial Intelligence (AI) and Machine Learning (ML) has revolutionized the way legal professionals operate. One of the key components of this transformation is Natural Language Processing (NLP). This article explores the pivotal role that NLP plays…
-
Invention for Antibody-drug conjugates, and their uses
Invented by David M. Goldenberg, Serengulam V. Govindan, Immunomedics Inc The market for Antibody-drug conjugates (ADCs) is rapidly growing, driven by their potential to revolutionize cancer treatment. ADCs are a class of targeted therapies that combine the specificity of monoclonal antibodies with the cytotoxicity of small molecule drugs. This unique combination allows for highly targeted…
-
Invention for Antibody variants
Invented by Herman Waldmann, Lisa K Gilliland, Masahide Tone, Mark R Frewin, Louise Walsh, Oxford University Innovation Ltd The market for antibody variants has been rapidly growing in recent years, driven by the increasing demand for personalized medicine and targeted therapies. Antibodies are proteins produced by the immune system to identify and neutralize foreign substances,…
-
Invention for Combination of ABCG2 Inhibitors with Sacituzumab Govitecan (IMMU-132) Overcomes Resistance to SN-38 for Trop-2 expressing Cancers
Invented by Chien-Hsing Chang, David M. Goldenberg, Immunomedics Inc cancers. The market for combination therapies in cancer treatment is constantly evolving, with researchers and pharmaceutical companies striving to find new ways to overcome resistance and improve patient outcomes. One promising combination that has shown great potential is the use of ABCG2 inhibitors in conjunction with…
-
Invention for Bispecific antibodies that bind to CD38 andCD3
Invented by Matthew Bernett, Seung Chu, Gregory Moore, John Desjarlais, Xencor Inc The market for bispecific antibodies that bind to CD38 and CD3 is rapidly growing, thanks to their potential in treating various types of cancer. CD38 is a cell surface protein that is highly expressed on multiple myeloma cells, while CD3 is a protein…
-
Invention for Inhalable Dry Powders
Invented by Wesley H. Dehaan, Jean C. Sung, Diana Manzanedo, Ciaran Lawlor, Michael Tauber, Pulmatrix Operating Co Inc The market for inhalable dry powders has been steadily growing in recent years, driven by advancements in technology and a growing demand for convenient and effective respiratory treatments. Inhalable dry powders offer a non-invasive and user-friendly alternative…
-
Invention for Anti-HER2 antibodies, compositions and formulations
Invented by Mikkel Wandahl Pedersen, Allan Jensen, Per-Johan Meijer, Symphogen AS The market for Anti-HER2 antibodies, compositions, and formulations has been experiencing significant growth in recent years. HER2 (Human Epidermal Growth Factor Receptor 2) is a protein that is overexpressed in certain types of cancer, including breast and gastric cancer. Anti-HER2 antibodies are designed to…